Skip to main content
. 2022 Sep 15;17(9):e0274181. doi: 10.1371/journal.pone.0274181

Fig 3. Longitudinal change of antibodies in Group M.

Fig 3

Levels of SARS-CoV-2 antibodies in 14 mild to moderate cases (Group M) were tested. (A) Neutralizing antibody (B) Elecsys® anti-S (C) Elecsys® anti-N. The vertical axes are in logarithmic notation.